Change over period
From:
To:
Zoom:
- 3M
- 6M
- YTD
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
XOMA Corporation
NASDAQ XOMAO
Data sourced from
and
and
Download Data
XOMA Corporation Price to Operating Income Ratio (P/OI) on June 03, 2024: -12.01
XOMA Corporation Price to Operating Income Ratio (P/OI) is -12.01 on June 03, 2024, a 13.42% change year over year. The price to operating income ratio compares the market price per share of a company's stock to its operating income per share. It is calculated by dividing the market capitalization by the operating income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's operating income generation. A higher ratio suggests that investors are willing to pay a higher price for each unit of operating income, indicating positive market sentiment and expectations for future profitability.
-
XOMA Corporation 52-week high Price to Operating Income Ratio (P/OI) is -5.63 on October 03, 2023, which is 53.07% above the current Price to Operating Income Ratio (P/OI).
-
XOMA Corporation 52-week low Price to Operating Income Ratio (P/OI) is -13.87 on June 05, 2023, which is -15.50% below the current Price to Operating Income Ratio (P/OI).
-
XOMA Corporation average Price to Operating Income Ratio (P/OI) for the last 52 weeks is -8.83.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: XOMAO
| CEO | - |
| IPO Date | April 12, 2021 |
| Location | United States |
| Headquarters | 2200 Powell Street, EmeryVille, CA, United States, 94608 |
| Employees | 13 |
| Sector | Healthcare |
| Industry | Biotechnology |
Description
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Key trends
Similar companies
XOMA Corp
NA
NA
StockViz Staff
September 19, 2024
Any question? Send us an email